01
Evidence-to-Decision Assessments
Does your evidence support the decision at hand?
We evaluate whether your current clinical and real-world evidence package credibly supports your intended strategic decision or launch deliverable.
Our Core Advisory Services
We specialize in strategic engagements.
We work with our clients on structured engagements designed to turn complex, incomplete, or fragmented evidence into defensible strategies. Our role is to provide the strategic direction, frameworks, and recommendations that enable internal teams and external partners to execute with confidence.
02
Evidence Roadmaps
Sequenced for prioritizing evidence needs over time.
We build a sequenced, prioritized timeline of the priority evidence activities to consider next, organized by lifecycle urgency and stakeholder relevance.
03
Value Story / Evidence Narratives
A narrative anchored in what the data actually prove.
We translate available evidence into a structured value narrative while clearly defining where support remains limited.
04
Data Assessment Plans
Fit-for-purpose before you buy.
We define fit-for-purpose criteria, feasibility risks, and research endpoints to evaluate candidate data sources before you make a costly data purchase.
05
HEOR Research Plans
A tactical blueprint for HEOR execution.
We develop a tactical HEOR blueprint detailing study concepts, timing, dependencies, and stakeholder-specific relevance.
Additional Services
Targeted support for specific moments.
Competitive Evidence Benchmarking
We map your asset's evidence base directly against key competitors' published trials and HTA submissions, identifying strategic vulnerabilities and clarifying which claims you can credibly defend.
Due Diligence Evidence Appraisals
We provide rapid, high-stakes evaluations of target asset data rooms for Business Development & Licensing (BD&L) teams, pinpointing hidden market access risks prior to a licensing or investment decision.
Data-to-Decision Advisory Retainers
Recurring strategic support to interpret complex HEOR/access inputs, refine leadership recommendations, and objectively review materials generated by your tactical execution vendors.
Deliverables & Experience
Preview of deliverables
Representative engagements
Prelaunch evidence strategy in neuroscience
Evaluated existing clinical and HEOR package to determine whether they supported the intended payer value proposition. Identified material vulnerabilities, and prioritized evidence activities before launch.
RWD investment decision in rare disease
Defined the decision requirements, endpoints, population criteria, data elements, and feasibility standards that were needed to compare candidate data sources before purchase.
Integrated evidence plan review in immunology
Determined whether planned studies addressed stakeholder decisions or merely reflected separate functional priorities, then produced a sequenced evidence roadmap for the team.
Not sure which one you need?
Most engagements begin with an Evidence-to-Decision Assessment. The right deliverable usually reveals itself once the gap is honestly mapped.
Talk to us